Cartesian Therapeutics Income Statement (2015-2025) | RNAC

Income Statement Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 1.24M1.61M2.13M2.09M2.02M1.05M2.93M0.14M0.03M0.03M0.02M-0.35M-0.36M-0.38M0.90M0.01M0.01M-0.39M6.65M-0.27M-0.20M4.65M11.95M11.05M19.66M24.43M29.94M34.00M39.27M20.71M16.80M5.94M5.25M6.55M8.27M5.84M33.45M0.39M-0.76M1.10M0.30M0.45M
Operating items
Research & Development 4.97M5.48M7.21M6.65M6.00M6.02M11.03M11.04M10.99M9.50M13.62M11.14M14.41M11.88M10.26M7.35M12.13M8.10M15.15M14.72M10.73M13.96M15.09M13.00M14.46M20.95M20.32M17.69M19.18M16.54M18.97M18.62M17.78M13.00M21.85M9.74M12.66M11.40M11.31M14.67M14.87M13.80M
Selling, General & Administrative 1.87M2.19M2.03M2.38M2.42M2.50M5.76M3.88M4.90M4.38M5.67M4.67M4.36M4.06M5.15M4.51M4.11M3.69M4.07M4.10M5.64M4.42M4.76M5.20M4.75M5.45M5.54M5.54M6.23M5.77M6.32M5.70M6.11M6.61M22.04M9.45M7.03M6.56M7.09M8.31M7.24M7.72M
Other Operating Expenses 0.71M0.71M7.58M
Operating Expenses 7.55M7.68M9.24M9.03M8.42M8.52M16.79M14.92M15.90M13.88M19.29M15.81M18.77M15.94M15.40M11.87M16.25M11.79M19.22M18.82M16.37M18.38M19.85M18.21M19.21M26.40M25.86M23.23M25.41M22.31M25.29M24.32M23.89M19.62M44.60M19.19M19.69M17.96M25.97M22.99M22.11M21.52M
Operating Income -5.81M-6.07M-7.11M-6.94M-6.40M-7.47M-13.86M-14.78M-15.87M-13.85M-19.28M-15.81M-18.77M-15.94M-14.50M-11.86M-16.23M-11.79M-12.57M-18.82M-16.37M-13.73M-7.90M-7.16M0.45M-1.97M4.08M10.77M13.86M-1.60M-8.50M-18.38M-18.64M-13.06M-36.33M-13.35M13.76M-17.57M-26.73M-21.89M-21.81M-21.07M
EBIT -5.81M-6.07M-7.11M-6.94M-6.40M-7.47M-13.86M-14.78M-15.87M-13.85M-19.28M-15.81M-18.77M-15.94M-14.50M-11.86M-16.23M-11.79M-12.57M-18.82M-16.37M-13.73M-7.90M-7.16M0.45M-1.97M4.08M10.77M13.86M-1.60M-8.50M-18.38M-18.64M-13.06M-36.33M-13.35M13.76M-17.57M-26.73M-21.89M-21.81M-21.07M
Non-operating items
Non Operating Investment Income -149.60M-6.89M
Interest & Investment Income 0.06M0.03M0.02M0.01M0.01M0.10M0.11M0.11M0.10M0.17M0.24M0.29M0.25M0.29M0.22M0.28M0.25M0.18M0.13M0.24M0.01M0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.21M0.71M1.14M1.33M1.39M1.30M0.94M1.16M1.20M2.57M2.45M2.02M1.75M1.55M
Other Non Operating Income 0.19M0.67M0.32M-0.22M-0.16M-0.05M-0.10M-0.17M0.08M-0.67M0.03M-0.01M0.08M0.03M0.02M-0.07M-0.01M0.01M-1.24M0.08M0.06M-0.46M0.01M-0.01M0.01M0.15M-0.10M0.01M0.17M0.26M0.24M0.25M-0.06M0.51M0.29M0.25M-0.44M-0.01M
Non Operating Income -0.01M0.02M-0.02M-0.06M0.00M0.08M-0.02M-0.14M0.01M0.00M-0.00M-0.07M0.01M-0.00M-1.24M-0.00M0.06M0.01M0.03M0.01M0.01M0.15M0.00M0.17M0.26M0.24M0.25M-0.06M0.51M0.29M0.25M-0.44M-0.01M
Net income details
EBT -5.93M-6.38M-7.19M-7.24M-6.70M-7.68M-14.07M-14.97M-16.05M-13.96M-19.05M-15.88M-18.89M-16.03M-14.27M-11.97M-16.39M-12.00M-12.78M-18.86M-16.56M-9.73M-15.45M-7.86M-0.25M-2.07M12.38M10.08M13.35M-8.21M5.61M-17.86M-18.00M-9.00M-196.66M-12.18M14.95M-15.00M-24.28M-19.87M-20.06M-19.52M
Tax Provisions 15.83M0.14M-0.32M-0.29M
Profit After Tax -6.87M-5.72M-6.85M-7.48M-6.92M-7.73M-14.08M-15.13M-15.97M-14.68M-19.54M-15.89M-18.80M-16.00M-14.65M-12.07M-16.39M-11.99M-14.89M-19.62M-24.08M-9.73M-15.45M-24.60M4.57M-17.89M12.24M28.78M8.60M-7.89M5.89M-21.66M-11.39M-9.00M-177.66M-56.82M13.84M-24.18M-10.25M-17.71M15.89M-35.90M
Income from Continuing Operations -5.93M-6.38M-7.19M-7.24M-6.70M-7.68M-14.07M-14.97M-16.05M-13.96M-19.05M-15.88M-18.89M-16.03M-14.27M-11.97M-16.39M-12.00M-12.78M-18.86M-16.56M-9.73M-15.45M-7.86M-0.25M-17.89M12.24M10.08M13.35M-7.89M5.89M-17.86M-18.00M-9.00M-196.66M-12.18M14.95M-15.00M-24.28M-19.87M-20.06M-19.52M
Consolidated Net Income -5.93M-6.38M-7.19M-7.24M-6.70M-7.68M-14.07M-14.97M-16.05M-13.96M-19.05M-15.88M-18.89M-16.03M-14.27M-11.97M-16.39M-12.00M-12.78M-18.86M-16.56M-9.73M-15.45M-7.86M-0.25M-17.89M12.24M10.08M13.35M-7.89M5.89M-17.86M-18.00M-9.00M-196.66M-12.18M14.95M-15.00M-24.28M-19.87M-20.06M-19.52M
Income towards Parent Company -5.93M-6.38M-7.19M-7.24M-6.70M-7.68M-14.07M-14.97M-16.05M-13.96M-19.05M-15.88M-18.89M-16.03M-14.27M-11.97M-16.39M-12.00M-12.78M-18.86M-16.56M-9.73M-15.45M-7.86M-0.25M-17.89M12.24M10.08M13.35M-7.89M5.89M-17.86M-18.00M-9.00M-196.66M-12.18M14.95M-15.00M-24.28M-19.87M-20.06M-19.52M
Preferred Dividend Payments 1.56M1.84M2.38M2.36M2.21M-4.21M-2.63M
Net Income towards Common Stockholders -8.43M-7.56M-9.22M-9.83M-9.13M-7.73M-14.08M-15.13M-15.97M-14.68M-19.54M-15.89M-18.80M-16.00M-14.65M-12.07M-16.39M-11.99M-12.78M-18.86M-16.56M-9.73M-15.45M-7.86M-0.25M-17.89M12.24M10.08M13.35M-7.89M5.89M-17.86M-21.66M-9.00M-196.66M-12.18M-52.62M-15.00M-24.28M-19.87M-15.08M-19.52M
Additional items
EPS (Basic) -3.93-3.50-4.26-4.52-2.75-0.43-0.77-0.82-0.85-0.66-0.88-0.71-0.84-0.71-0.65-0.31-0.37-0.26-0.28-0.21-0.25-0.09-0.14-0.220.04-0.160.120.230.06-0.050.03-4.24-2.23-1.74-41.56-10.500.58-1.130.13-0.680.51-1.38
EPS (Weighted Average and Diluted) -0.28-0.21-0.09-0.14-0.220.00-0.160.120.080.06-0.05-0.05-4.24-2.23-1.74-41.56-10.500.54-1.130.12-0.680.50-1.38
Shares Outstanding (Weighted Average) 0.56M0.61M0.61M0.61M0.62M0.62M0.74M0.74M0.74M0.74M0.75M0.75M1.49M1.49M1.50M1.61M2.88M2.92M3.57M3.60M3.75M3.77M3.84M3.89M4.14M5.06M5.09M5.10M5.11M5.11M5.11M5.17M5.40M17.80M24.33M25.41M25.91M25.95M26.00M
Shares Outstanding (Diluted Average) 45.55M96.79M105.33M101.20M110.74M121.18M115.17M114.33M127.57M148.51M152.85M145.87M5.11M5.11M5.16M5.17M5.41M17.79M21.47M17.36M25.90M26.45M26.00M
EBITDA -5.81M-6.53M-7.20M-7.25M-6.75M-7.70M-14.05M-15.00M-16.00M-14.67M-19.55M-15.87M-18.87M-16.04M-14.69M-12.05M-16.39M-12.00M-14.88M-19.68M-24.05M-9.76M-15.43M-24.60M4.58M-17.90M12.23M28.75M8.72M-7.94M5.87M-21.67M-11.41M-9.02M-177.64M-56.83M13.85M-24.20M-10.27M-17.68M15.90M-35.91M
Interest Expenses 0.18M0.33M0.10M0.31M0.31M0.31M0.32M0.30M0.28M0.27M0.01M0.35M0.36M0.38M-0.01M0.40M0.40M0.39M0.34M0.27M0.20M0.36M0.71M0.71M0.71M0.71M0.71M0.71M0.71M0.80M0.81M0.81M0.75M1.27M
Tax Rate 1.11%3.91%